Clinical Cardiology Alert – June 1, 2015
June 1, 2015
View Issues
-
FDA Approves Ivabradine for Systolic Heart Failure
ABSTRACT & COMMENTARY: In HF patients with a heart rate above 70 bpm, despite truly maximum-tolerated doses of beta-blockers, ivabradine is an option.
-
Valve Thrombosis After TAVR: Is It as Rare as We Thought?
A CT study demonstrates that valve thrombosis may be more common than earlier thought.
-
Endovascular Intervention Takes Center Stage in Treatment of Acute Stroke
Two studies join a growing body of recent evidence supporting improved clinical outcomes with interventional treatment of acute stroke.
-
Antibiotic Prophylaxis Guidelines and Endocarditis Rates
Despite the limitations of this type of study, it supports the U.S. view of treating high-risk patients with antibiotic prophylaxis.
-
The Echo Calcium Score
Aortic valve sclerosis and mitral annular calcification detected by echocardiography are known to be associated with atherosclerosis and are predictive of cardiovascular morbidity and mortality.
-
Insights into the Association of Atrial Fibrillation and Myocardial Infarction
Given the mounting evidence suggesting that stroke, MI, and AF have pathophysiologic mechanisms in common, the presence of any one should at a minimum heighten suspicion for the others.